• Mira Smart Conferencing
  • Home
  • Table of Contents
  • Advanced Search
 
Advanced Search

Browse All

Current Filters

CLEAR FILTER x

TITLE

Session Name:

  • P2: MS Immunology and Basic Science

Filter

Partial Search: Partial searches may be entered manually by pressing enter in the filter input field.
Author Filter: Selecting one or more Authors from the Author drop down list will filter results by Author last name(s) only.

Displaying 16 - 17 of 17

  • Page:
  • 2
  • 3
  • 4

Immune Response Following COVID-19 Vaccination (mRNA or Non-mRNA) in Patients with Relapsing Multiple Sclerosis Treated with the Bruton’s Tyrosine Kinase Inhibitor Evobrutinib: An Update

Author:Bar-Or, Amit   Cross, Anne H.   Cunningham, Anthony   Hyvert, Yann   Seitzinger, Andrea   Drouin, Elise E.   Alexandri, Nektaria   Tomic, Davorka   Montalban, Xavier   

Session Name:P2: MS Immunology and Basic Science  

Topic:MS and Inflammatory Disease  

Program Number:P2.017  

Author Institution:Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA  Washington University School of Medicine, St. Louis, MO  The Westmead Institute for Medical Research, The University of Sydney, Westmead, Australia  the healthcare business of Merck KGaA, Darmstadt, Germany, Darmstadt, Germany  EMD Serono, Billerica, MA  Ares Trading SA, Eysins, Switzerland, an affiliate of Merck KGaA, Darmstadt, Germany , Eysins, Switzerland  Centre d’Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d’Hebron, Barcelona, Spain  

  • View Abstract
  • View Disclosure

Serologic Response and Clinical Outcomes of SARS-CoV-2 Infection and Vaccination in Ozanimod-Treated Participants With Relapsing Multiple Sclerosis

Author:Cree, Bruce A. C.   Maddux, Rachel   Bar-Or, Amit   Hartung, Hans-Peter   Kaur, Amandeep   Brown, Elizabeth   Hu, Sarah   Sheffield, James   Silva, Diego   Harris, Sarah   

Session Name:P2: MS Immunology and Basic Science  

Topic:MS and Inflammatory Disease  

Program Number:P2.018  

Author Institution:Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, California, San Francisco, CA  Bristol Myers Squibb, Princeton, New Jersey, Princeton, NJ  Center for Neuroinflammation and Experimental Therapeutics, and Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, Philadelphia, PA  Department of Neurology, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany  Brain and Mind Centre, University of Sydney, Sydney, Australia  Department of Neurology, Medical University of Vienna, Vienna, Austria  and Palacký University Olomouc, Olomouc, Czech Republic, Dusseldorf, Germany  Bristol Myers Squibb, Princeton, New Jersey, San Diego, CA  

  • View Abstract
  • View Disclosure

Displaying 16 - 17 of 17

  • Page:
  • 2
  • 3
  • 4

© 2015 Mira Smart Conference | http://www.mirasmart.com